Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV3-20	1.85e-05	190	119	8	GO:0003823
GeneOntologyMolecularFunction	calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity	PDE1A PDE1B	1.05e-04	3	119	2	GO:0048101
GeneOntologyMolecularFunction	calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity	PDE1A PDE1B	1.05e-04	3	119	2	GO:0004117
GeneOntologyBiologicalProcess	immunoglobulin production	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-20	1.89e-12	241	127	16	GO:0002377
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 MALT1 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-20	4.72e-10	403	127	17	GO:0002440
GeneOntologyBiologicalProcess	adaptive immune response	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 MALT1 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-20 NCKAP1L	3.84e-06	838	127	18	GO:0002250
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-20	4.03e-15	166	126	16	GO:0019814
GeneOntologyCellularComponent	IgM immunoglobulin complex, circulating	IGKV3D-20 IGKV3D-11 IGKV3-20	1.17e-05	8	126	3	GO:0071754
GeneOntologyCellularComponent	pentameric IgM immunoglobulin complex	IGKV3D-20 IGKV3D-11 IGKV3-20	1.17e-05	8	126	3	GO:0071756
GeneOntologyCellularComponent	monomeric IgA immunoglobulin complex	IGKV3D-20 IGKV3D-11 IGKV3-20	1.75e-05	9	126	3	GO:0071748
GeneOntologyCellularComponent	polymeric IgA immunoglobulin complex	IGKV3D-20 IGKV3D-11 IGKV3-20	2.49e-05	10	126	3	GO:0071749
GeneOntologyCellularComponent	IgA immunoglobulin complex, circulating	IGKV3D-20 IGKV3D-11 IGKV3-20	2.49e-05	10	126	3	GO:0071746
GeneOntologyCellularComponent	secretory IgA immunoglobulin complex	IGKV3D-20 IGKV3D-11 IGKV3-20	2.49e-05	10	126	3	GO:0071751
GeneOntologyCellularComponent	IgA immunoglobulin complex	IGKV3D-20 IGKV3D-11 IGKV3-20	9.23e-05	15	126	3	GO:0071745
GeneOntologyCellularComponent	IgM immunoglobulin complex	IGKV3D-20 IGKV3D-11 IGKV3-20	9.23e-05	15	126	3	GO:0071753
GeneOntologyCellularComponent	immunoglobulin complex, circulating	IGKV3D-20 IGKV3D-11 IGKV3-20	1.37e-04	17	126	3	GO:0042571
GeneOntologyCellularComponent	photoreceptor connecting cilium	PCDHB13 PCDHB8 KIAA1549 IFT52	1.99e-04	48	126	4	GO:0032391
GeneOntologyCellularComponent	blood microparticle	IGKV1-39 IGKV1-17 IGKV1-5 IGKV1D-33 IGKV1D-12 IGKV3-20	2.41e-04	144	126	6	GO:0072562
GeneOntologyCellularComponent	dynein complex	TPR DNAH1 DYNC1H1 DYNC1LI2	3.15e-04	54	126	4	GO:0030286
GeneOntologyCellularComponent	cytoplasmic dynein complex	TPR DYNC1H1 DYNC1LI2	3.95e-04	24	126	3	GO:0005868
GeneOntologyCellularComponent	cilium	PDE1A ABCC4 FBXL13 SPEF2 PCDHB13 PCDHB8 ARFGEF2 KIAA1549 CDH23 DNAH1 IFT52 VCAN KCNJ10 TEKT4	1.04e-03	898	126	14	GO:0005929
GeneOntologyCellularComponent	non-motile cilium	PCDHB13 PCDHB8 KIAA1549 CDH23 IFT52 VCAN	1.22e-03	196	126	6	GO:0097730
GeneOntologyCellularComponent	ciliary transition zone	PCDHB13 PCDHB8 KIAA1549 IFT52	1.46e-03	81	126	4	GO:0035869
GeneOntologyCellularComponent	photoreceptor cell cilium	PCDHB13 PCDHB8 KIAA1549 IFT52 VCAN	1.55e-03	139	126	5	GO:0097733
GeneOntologyCellularComponent	9+0 non-motile cilium	PCDHB13 PCDHB8 KIAA1549 IFT52 VCAN	2.36e-03	153	126	5	GO:0097731
Domain	-	COL6A3 SEC24A MATN3 COL6A5 ITIH3	7.54e-05	74	110	5	3.40.50.410
Domain	PDEase_N	PDE1A PDE1B	1.03e-04	3	110	2	IPR013706
Domain	PDEase_I_N	PDE1A PDE1B	1.03e-04	3	110	2	PF08499
Domain	DCB_dom	ARFGEF2 ARFGEF1	2.05e-04	4	110	2	IPR032629
Domain	Sec7_C	ARFGEF2 ARFGEF1	2.05e-04	4	110	2	IPR015403
Domain	DUF1981	ARFGEF2 ARFGEF1	2.05e-04	4	110	2	PF09324
Domain	Sec7_N	ARFGEF2 ARFGEF1	2.05e-04	4	110	2	IPR032691
Domain	Sec7_N	ARFGEF2 ARFGEF1	2.05e-04	4	110	2	PF12783
Domain	DCB	ARFGEF2 ARFGEF1	2.05e-04	4	110	2	PF16213
Domain	VWF_A	COL6A3 SEC24A MATN3 COL6A5 ITIH3	2.98e-04	99	110	5	IPR002035
Domain	VWA	COL6A3 MATN3 COL6A5 ITIH3	3.30e-04	56	110	4	PF00092
Domain	Cadherin_CS	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	4.65e-04	109	110	5	IPR020894
Domain	RNase_PH_C	EXOSC8 PNPT1	5.08e-04	6	110	2	PF03725
Domain	-	EXOSC8 PNPT1	5.08e-04	6	110	2	3.30.230.70
Domain	PNPase/RNase_PH_dom	EXOSC8 PNPT1	5.08e-04	6	110	2	IPR027408
Domain	CADHERIN_1	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	5.48e-04	113	110	5	PS00232
Domain	Cadherin	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	5.48e-04	113	110	5	PF00028
Domain	CADHERIN_2	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	5.70e-04	114	110	5	PS50268
Domain	-	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	5.70e-04	114	110	5	2.60.40.60
Domain	CA	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	5.94e-04	115	110	5	SM00112
Domain	Cadherin-like	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	6.17e-04	116	110	5	IPR015919
Domain	Cadherin	DCHS2 DSG2 PCDHB13 PCDHB8 CDH23	6.67e-04	118	110	5	IPR002126
Domain	ExoRNase_PH_dom2	EXOSC8 PNPT1	7.08e-04	7	110	2	IPR015847
Domain	RNase_PH	EXOSC8 PNPT1	7.08e-04	7	110	2	PF01138
Domain	HATC_C_dom	ZNF862 SPEF2	9.40e-04	8	110	2	IPR008906
Domain	Dimer_Tnp_hAT	ZNF862 SPEF2	9.40e-04	8	110	2	PF05699
Domain	Ribosomal_S5_D2-typ_fold	EXOSC8 EFTUD2 PNPT1	1.04e-03	34	110	3	IPR020568
Domain	VWFA	COL6A3 MATN3 COL6A5 ITIH3	1.40e-03	82	110	4	PS50234
Domain	ExoRNase_PH_dom1	EXOSC8 PNPT1	1.50e-03	10	110	2	IPR001247
Domain	VWA	COL6A3 MATN3 COL6A5 ITIH3	1.53e-03	84	110	4	SM00327
Domain	EGF_3	MATN3 CUBN LRP1B CNTNAP5 VCAN OTOG	2.69e-03	235	110	6	PS50026
Domain	Dynein_heavy_chain_D4_dom	DNAH1 DYNC1H1	2.99e-03	14	110	2	IPR024317
Domain	Dynein_HC_stalk	DNAH1 DYNC1H1	2.99e-03	14	110	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH1 DYNC1H1	2.99e-03	14	110	2	IPR013602
Domain	DHC_N2	DNAH1 DYNC1H1	2.99e-03	14	110	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH1 DYNC1H1	2.99e-03	14	110	2	IPR011704
Domain	MT	DNAH1 DYNC1H1	2.99e-03	14	110	2	PF12777
Domain	AAA_8	DNAH1 DYNC1H1	2.99e-03	14	110	2	PF12780
Domain	AAA_5	DNAH1 DYNC1H1	2.99e-03	14	110	2	PF07728
Domain	DHC_fam	DNAH1 DYNC1H1	3.43e-03	15	110	2	IPR026983
Domain	Dynein_heavy	DNAH1 DYNC1H1	3.43e-03	15	110	2	PF03028
Domain	-	ARFGEF2 ARFGEF1	3.43e-03	15	110	2	1.10.1000.11
Domain	Dynein_heavy_dom	DNAH1 DYNC1H1	3.43e-03	15	110	2	IPR004273
Domain	Sec7	ARFGEF2 ARFGEF1	3.43e-03	15	110	2	PF01369
Domain	Sec7_alpha_orthog	ARFGEF2 ARFGEF1	3.43e-03	15	110	2	IPR023394
Domain	EGF-like_dom	MATN3 CUBN LRP1B CNTNAP5 VCAN OTOG	3.57e-03	249	110	6	IPR000742
Domain	Quinoprotein_ADH-like_supfam	EML6 AASDH PWP2	3.76e-03	53	110	3	IPR011047
Domain	SEC7	ARFGEF2 ARFGEF1	3.91e-03	16	110	2	PS50190
Domain	Sec7	ARFGEF2 ARFGEF1	3.91e-03	16	110	2	SM00222
Domain	Sec7_dom	ARFGEF2 ARFGEF1	3.91e-03	16	110	2	IPR000904
Domain	PDEase	PDE1A PDE1B	5.51e-03	19	110	2	IPR023088
Domain	EGF_CA	MATN3 CUBN LRP1B VCAN	5.88e-03	122	110	4	SM00179
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	1.10e-16	61	94	13	M27581
Pathway	REACTOME_FCGR_ACTIVATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	6.22e-16	69	94	13	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	6.22e-16	69	94	13	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	9.25e-16	71	94	13	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	9.25e-16	71	94	13	M27203
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	4.78e-15	80	94	13	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	6.69e-15	82	94	13	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	1.28e-14	86	94	13	M601
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	1.28e-14	86	94	13	M27206
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	1.49e-14	87	94	13	M27205
Pathway	REACTOME_PARASITE_INFECTION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11 NCKAP1L	2.94e-14	116	94	14	M29843
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	4.88e-14	95	94	13	M29842
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	7.40e-14	98	94	13	M27152
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 MALT1 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	2.77e-13	136	94	14	M27207
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11 NCKAP1L	5.58e-13	143	94	14	M27107
Pathway	REACTOME_COMPLEMENT_CASCADE	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	6.14e-13	115	94	13	M19752
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IFNGR2 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	1.56e-12	154	94	14	M39007
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 MALT1 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	4.37e-12	166	94	14	M608
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	4.49e-12	134	94	13	M29840
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 MALT1 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	2.06e-11	186	94	14	M27175
Pathway	REACTOME_LEISHMANIA_INFECTION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11 NCKAP1L	1.83e-10	219	94	14	M29836
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	3.72e-10	190	94	13	M8240
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	4.82e-10	194	94	13	M16312
Pathway	REACTOME_SARS_COV_INFECTIONS	IGKV1-39 IGKV1-33 TPR IGKV1-17 IGKV1-16 IGKV1-12 ANO9 SEC24A IFNGR2 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	1.19e-08	471	94	17	M39009
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 FBXL13 SEC24A IGKV1-5 MALT1 ANAPC2 IGKV3D-20 GAN IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 DYNC1H1 IGKV3-11 DYNC1LI2 HERC5	8.72e-08	828	94	21	M1058
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 SEC24A SEC31B IGKV1-5 SYNJ1 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 DYNC1H1 IGKV3-11 DYNC1LI2	1.16e-06	725	94	18	M27507
Pathway	REACTOME_VIRAL_INFECTION_PATHWAYS	IGKV1-39 IGKV1-33 TPR IGKV1-17 IGKV1-16 IGKV1-12 ANO9 SEC24A IFNGR2 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 DYNC1H1 IGKV3-11 DYNC1LI2 HERC5	1.23e-06	888	94	20	M48034
Pathway	REACTOME_HEMOSTASIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 PDE1A ABCC4 PDE1B ITIH3 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 IGKV3-11	2.15e-06	679	94	17	M8395
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	IGKV1-39 HEXB IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 OLFM4 MUC16 IGKV1-5 MALT1 SERPINB12 IGKV3D-20 IGKV1D-39 MAPK11 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 DYNC1H1 IGKV3-11 HERC5 NCKAP1L	3.57e-06	1128	94	22	M1036
Pathway	REACTOME_INFECTIOUS_DISEASE	IGKV1-39 IGKV1-33 TPR IGKV1-17 IGKV1-16 IGKV1-12 ANO9 SEC24A IFNGR2 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV3-20 DYNC1H1 IGKV3-11 DYNC1LI2 HERC5 NCKAP1L	6.66e-06	1081	94	21	M27548
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL6A3 MATN3 COL6A5 VCAN	2.66e-04	47	94	4	MM14925
Pathway	REACTOME_CAM_PDE_1_ACTIVATION	PDE1A PDE1B	6.48e-04	6	94	2	MM14494
Pubmed	Variation in the crossover point of kappa immunoglobulin gene V-J recombination: evidence from a cryptic gene.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV1D-13	1.24e-22	9	132	9	6777049
Pubmed	Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13	2.51e-22	20	132	11	10427970
Pubmed	Structure and implied functions of truncated B-cell receptor mRNAs in early embryo and adult mesenchymal stem cells: Cdelta replaces Cmu in mu heavy chain-deficient mice.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV1D-13	1.38e-18	16	132	9	17124007
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV3-20	2.77e-18	77	132	13	15608191
Pubmed	Human myeloperoxidase in innate and acquired immunity.	IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-12	5.85e-18	18	132	9	20399194
Pubmed	Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.	IGKV1-39 IGKV1-13 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-13	3.15e-15	11	132	7	6795447
Pubmed	Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.	IGKV1-39 IGKV1-13 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-13	3.15e-15	11	132	7	279004
Pubmed	Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes.	IGKV1-39 IGKV1-13 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-13	3.15e-15	11	132	7	6767723
Pubmed	The V kappa genes of the L regions and the repertoire of V kappa gene sequences in the human germ line.	IGKV1-17 IGKV1-12 IGKV3D-11 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-11	1.82e-13	17	132	7	8223863
Pubmed	Evolutionary dynamics of the human immunoglobulin kappa locus and the germline repertoire of the Vkappa genes.	IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12	9.61e-13	36	132	8	11298326
Pubmed	Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous.	IGKV1-33 IGKV1-6 IGKV1D-33	5.34e-08	3	132	3	1940382
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 DCHS2 ACACB SPEG MATN3 NSUN7 GAN IGKV1D-39 IGKV1D-33 IGKV1D-16	6.10e-08	497	132	13	36774506
Pubmed	A large section of the gene locus encoding human immunoglobulin variable regions of the kappa type is duplicated.	IGKV3D-11 IGKV1D-13 IGKV1D-12	2.13e-07	4	132	3	3927006
Pubmed	Organization and evolution of a gene cluster for human immunoglobulin variable regions of the kappa type.	IGKV1-13 IGKV1-12 IGKV1-9	5.31e-07	5	132	3	6086934
Pubmed	Primary structures of N-terminal extra peptide segments linked to the variable and constant regions of immunoglobulin light chain precursors: implications on the organization and controlled expression of immunoglobulin genes.	IGKV3D-20 IGKV3D-11 IGKV3-20	1.06e-06	6	132	3	98179
Pubmed	Mechanisms of antibody diversity: multiple genes encode structurally related mouse kappa variable regions.	IGKV3D-20 IGKV3D-11 IGKV3-20	1.06e-06	6	132	3	99744
Pubmed	Mouse immunoglobulin chains. Pattern of sequence variation among kappa chains with limited sequence differences.	IGKV3D-20 IGKV3D-11 IGKV3-20	1.06e-06	6	132	3	4691517
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-33 IGKV3-20	1.10e-06	48	132	5	11955599
Pubmed	Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.	IGKV1-39 IGKV1-17 IGKV1-5 IGKV3D-11 IGKV1D-33 IGKV1D-12 IGKV3-20	1.32e-06	143	132	7	22516433
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PDXDC1 ACACB DSG2 SEC24A ARFGEF2 ARFGEF1 MUC16 CEP192 BIRC6 EFTUD2 ROBO1 AFDN DYNC1H1 DYNC1LI2	1.66e-06	777	132	14	35844135
Pubmed	The 3' part of the immunoglobulin kappa locus of the mouse.	IGKV3D-20 IGKV3D-11 IGKV3-20	1.85e-06	7	132	3	9603450
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	IGKV1-39 HEXB IGKV1-17 DDAH2 COL6A3 CEL OLFM4 CUBN ITIH3 IGKV1-5 IGKV3D-11 ATIC IGKV1D-33 IGKV1D-12 IGKV3-20 DYNC1H1	3.22e-06	1070	132	16	23533145
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DSG2 SEC24A CEP192 SYNJ1 N4BP2 GAN MACF1 AFDN AKAP13 TNKS1BP1 PLEKHM3 TRAPPC14 OTOG AHNAK2	5.39e-06	861	132	14	36931259
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	IGKV1-39 IGKV1-33 TPR IGKV1-17 ADAR HMG20A EFTUD2 IGKV1-5 SERPINB12 IGKV1D-33 IGKV1D-12 IGKV3-20	7.69e-06	652	132	12	31180492
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR DSG2 IARS1 MACF1 TNKS1BP1 ATIC DYNC1H1 DYNC1LI2 AHNAK2	1.02e-05	360	132	9	33111431
Pubmed	Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma.	IGKV1-12 IGKV1D-12	1.43e-05	2	132	2	6776411
Pubmed	Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus.	IGKV1-12 IGKV1D-12	1.43e-05	2	132	2	8325334
Pubmed	Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants.	PDE1A PDE1B	1.43e-05	2	132	2	11747989
Pubmed	Phage display of a human antibody against Clostridium tetani toxin.	IGKV1-39 IGKV1D-39	1.43e-05	2	132	2	7926831
Pubmed	Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.	ARFGEF2 ARFGEF1	1.43e-05	2	132	2	23918382
Pubmed	The Double Mutation DSG2-p.S363X and TBX20-p.D278X Is Associated with Left Ventricular Non-Compaction Cardiomyopathy: Case Report.	DSG2 TBX20	1.43e-05	2	132	2	34202524
Pubmed	Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.	ARFGEF2 ARFGEF1	1.43e-05	2	132	2	17360629
Pubmed	Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.	ARFGEF2 ARFGEF1	1.43e-05	2	132	2	10716990
Pubmed	Membrane association of the Arabidopsis ARF exchange factor GNOM involves interaction of conserved domains.	ARFGEF2 ARFGEF1	1.43e-05	2	132	2	18203920
Pubmed	Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli.	IGKV1-12 IGKV1D-12	1.43e-05	2	132	2	8372513
Pubmed	Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.	ARFGEF2 ARFGEF1	1.43e-05	2	132	2	10212200
Pubmed	Neuronal migration defects in the Loa dynein mutant mouse.	DNAH1 DYNC1H1	1.43e-05	2	132	2	21612657
Pubmed	Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffic between the trans-Golgi network and endosomes.	ARFGEF2 ARFGEF1	1.43e-05	2	132	2	18417613
Pubmed	Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.	HEXB CRYBG1 MACF1 AKAP13 DYNC1H1 NCKAP1L	1.86e-05	143	132	6	30397336
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	DDAH2 ABCC4 DSG2 CEP192 BIRC6 PNPLA6 ANAPC2 ABCD4 ROBO1 MACF1 AFDN TARBP1	2.03e-05	719	132	12	35337019
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HEXB PPP4R1 DCHS2 ETS2 ARFGEF2 SEC31B LRP1B HMG20A SYNJ1 ROBO1 MACF1 AFDN TMEM131 ATIC TARBP1 DYNC1H1	3.09e-05	1285	132	16	35914814
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PDXDC1 HEXB PPP4R1 IARS1 SEC24A ARFGEF2 DNAJB4 ZZEF1 BIRC6 EFTUD2 MACF1 TNKS1BP1 EIF3A ATIC DYNC1H1 DYNC1LI2 AHNAK2	3.82e-05	1455	132	17	22863883
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	TPR PDE1A PDE1B BIRC6 DYNC1H1 DYNC1LI2	3.89e-05	163	132	6	16512683
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR BIRC6 PNPT1 PWP2 MACF1 UTP20 AFDN TNKS1BP1 ATIC DYNC1H1 HERC5	4.18e-05	653	132	11	22586326
Pubmed	Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	19332778
Pubmed	Specific functions of BIG1 and BIG2 in endomembrane organization.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	20360857
Pubmed	The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways.	INSIG1 EIF3A	4.28e-05	3	132	2	20068067
Pubmed	The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway.	AKAP13 MAPK11	4.28e-05	3	132	2	11579095
Pubmed	Immunoglobulin genes of the kappa light chain type from two human lymphoid cell lines are closely related.	IGKV1-39 IGKV1D-39	4.28e-05	3	132	2	6091049
Pubmed	AMY-1 (associate of Myc-1) localization to the trans-Golgi network through interacting with BIG2, a guanine-nucleotide exchange factor for ADP-ribosylation factors.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	16866877
Pubmed	Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.	PDE1A PDE1B	4.28e-05	3	132	2	9003415
Pubmed	Systematic dissection of dynein regulators in mitosis.	DNAH1 DYNC1H1	4.28e-05	3	132	2	23589491
Pubmed	A C-terminal sequence in the guanine nucleotide exchange factor Sec7 mediates Golgi association and interaction with the Rsp5 ubiquitin ligase.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	18832381
Pubmed	Kinetic properties of Ca2+/calmodulin-dependent phosphodiesterase isoforms dictate intracellular cAMP dynamics in response to elevation of cytosolic Ca2+.	PDE1A PDE1B	4.28e-05	3	132	2	18335582
Pubmed	[Rule of antibody structure. The primary structure of a monoclonal immunoglobulin L-chain of kappa-type, subgroup 3 (Bence-Jones protein Ti). IV. The complete amino acid sequence and its significance for the mechanism of antibody production].	IGKV3D-20 IGKV3-20	4.28e-05	3	132	2	5027703
Pubmed	Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons.	PDE1A PDE1B	4.28e-05	3	132	2	7568196
Pubmed	Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.	INSIG1 PPARD	4.28e-05	3	132	2	18627005
Pubmed	Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	31199673
Pubmed	Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes.	PDE1A PDE1B	4.28e-05	3	132	2	17726023
Pubmed	Matrilin-3 inhibits chondrocyte hypertrophy as a bone morphogenetic protein-2 antagonist.	MATN3 BMP2	4.28e-05	3	132	2	25331953
Pubmed	Distinct functions for Arf guanine nucleotide exchange factors at the Golgi complex: GBF1 and BIGs are required for assembly and maintenance of the Golgi stack and trans-Golgi network, respectively.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	18003980
Pubmed	Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	27162341
Pubmed	The Sec7 guanine nucleotide exchange factor GBF1 regulates membrane recruitment of BIG1 and BIG2 guanine nucleotide exchange factors to the trans-Golgi network (TGN).	ARFGEF2 ARFGEF1	4.28e-05	3	132	2	23386609
Pubmed	Immunoglobulin genes of different subgroups are interdigitated within the VK locus.	IGKV3D-11 IGKV3-11	4.28e-05	3	132	2	6440122
Pubmed	A crucial role for Arf6 in the response of commissural axons to Slit.	ARFGEF2 ARFGEF1 ROBO1	4.95e-05	19	132	3	30674481
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	ARFGEF2 ARFGEF1 PNPLA6 AKAP13 TARBP1	4.97e-05	104	132	5	31240132
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HEXB ABCC4 DSG2 ARFGEF2 ARFGEF1 KIAA1549 DNAJB4 EXTL2 ZZEF1 LRP1B ROBO1 UTP20 TNKS1BP1 TMEM131 EIF3A	5.37e-05	1201	132	15	35696571
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TPR DSG2 ROBO1 TNKS1BP1 DYNC1H1 KNL1 AHNAK2	5.82e-05	256	132	7	33397691
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR ACACB DSG2 ADAR EFTUD2 SYNJ1 MACF1 TNKS1BP1 EIF3A ATIC HERC5 KNL1 AHNAK2	5.92e-05	934	132	13	33916271
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	PDXDC1 IARS1 ZZEF1 DNAH1 EFTUD2 PACS2 MACF1 AKAP13 EIF3A ATIC DYNC1H1 AHNAK2	6.18e-05	807	132	12	30575818
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TPR ARFGEF2 SEC31B EFTUD2 ANAPC2 MACF1 TNKS1BP1 DYNC1H1 DYNC1LI2 KNL1	8.02e-05	582	132	10	20467437
Pubmed	Evolution of immunoglobulin V genes: evidence indicating that recently duplicated human V kappa sequences have diverged by gene conversion.	IGKV1-16 IGKV1D-16	8.54e-05	4	132	2	6402305
Pubmed	Differences between germ-line and rearranged immunoglobulin V kappa coding sequences suggest a localized mutation mechanism.	IGKV1-12 IGKV1D-12	8.54e-05	4	132	2	6264318
Pubmed	Human NB-2 of the contactin subgroup molecules: chromosomal localization of the gene (CNTN5) and distinct expression pattern from other subgroup members.	ARFGEF2 ARFGEF1	8.54e-05	4	132	2	11013081
Pubmed	Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.	ARFGEF2 ARFGEF1	8.54e-05	4	132	2	12606707
Pubmed	Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma.	CRYBG1 KNL1	8.54e-05	4	132	2	8700511
Pubmed	Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).	ARFGEF2 ARFGEF1	8.54e-05	4	132	2	12571360
Pubmed	Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.	ARFGEF2 ARFGEF1	8.54e-05	4	132	2	22084092
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	TPR DSG2 IARS1 EXOSC8 ADAR EFTUD2 PNPLA6 SERPINB12 PWP2 CRYBG1 GAN UTP20 TNKS1BP1 EIF3A DYNC1H1	8.93e-05	1257	132	15	36526897
Pubmed	Functional proteomics mapping of a human signaling pathway.	ETS2 ARFGEF2 PPARD ZZEF1 HMG20A ANAPC2 MACF1 AFDN DYNC1H1 KNL1	9.10e-05	591	132	10	15231748
Pubmed	Extensive molecular differences between anterior- and posterior-half-sclerotomes underlie somite polarity and spinal nerve segmentation.	HEXB TPR ETS2 ROBO1	9.32e-05	62	132	4	19463158
Pubmed	A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.	EFTUD2 ANAPC2 DYNC1H1	1.02e-04	24	132	3	33705438
Pubmed	Differential and restricted expression of novel collagen VI chains in mouse.	COL6A3 COL6A5	1.42e-04	5	132	2	21477648
Pubmed	Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning.	DNAH1 DYNC1H1	1.42e-04	5	132	2	19286658
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A3 COL6A5	1.42e-04	5	132	2	23869615
Pubmed	The human immunoglobulin kappa locus. Characterization of the duplicated O regions.	IGKV1-39 IGKV1D-39	1.42e-04	5	132	2	1907917
Pubmed	Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis.	BMP2 VCAN TBX20	1.46e-04	27	132	3	23824573
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR DSG2 IARS1 ADAR EFTUD2 SERPINB12 PWP2 MACF1 UTP20 AFDN EIF3A ATIC DYNC1H1	1.48e-04	1024	132	13	24711643
Pubmed	Defining the membrane proteome of NK cells.	HEXB ABCC4 IARS1 ARFGEF2 ADAR BIRC6 EFTUD2 PNPLA6 AKAP13 EIF3A ATIC DYNC1H1 DYNC1LI2 NCKAP1L	1.48e-04	1168	132	14	19946888
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CEP192 HELB ROBO1 MACF1 TNKS1BP1 EIF3A	1.53e-04	209	132	6	36779422
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TPR IARS1 ADAR BIRC6 EFTUD2 PNPLA6 SERPINB12 MACF1 UTP20 AFDN AKAP13 EIF3A ATIC DYNC1H1 AHNAK2	1.99e-04	1353	132	15	29467282
Pubmed	In vitro reconstitution of a highly processive recombinant human dynein complex.	DYNC1H1 DYNC1LI2	2.12e-04	6	132	2	24986880
Pubmed	Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alpha.	ROBO1 MACF1	2.12e-04	6	132	2	12719437
Pubmed	The human VK locus. Characterization of a duplicated region encoding 28 different immunoglobulin genes.	IGKV3D-20 IGKV3-20	2.12e-04	6	132	2	3351922
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	IARS1 EML6 ADAR MACF1 TNKS1BP1 DYNC1H1 AHNAK2	2.88e-04	332	132	7	37433992
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	FBXL13 ETS2 CDH23 ADAR MACF1	2.96e-04	152	132	5	34299191
Pubmed	Trim58 degrades Dynein and regulates terminal erythropoiesis.	DYNC1H1 DYNC1LI2	2.97e-04	7	132	2	25241935
Pubmed	The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice.	BMP2 MAPK11	2.97e-04	7	132	2	20551513
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A3 COL6A5	2.97e-04	7	132	2	18276594
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A3 COL6A5	2.97e-04	7	132	2	18400749
Interaction	FBXO22 interactions	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 DCHS2 ACACB SPEG MATN3 NSUN7 EFTUD2 GAN IGKV1D-39 IGKV1D-33 IGKV1D-16	6.08e-06	540	124	14	int:FBXO22
Cytoband	2p12	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	3.67e-28	117	132	19	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p11	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	5.28e-23	213	132	19	chr2p11
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	3.33e-26	83	99	19	351
Coexpression	SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	IGKV1-39 IGKV1-12 IGKV1-5 IGKV3-20 IGKV3-11	1.07e-08	16	128	5	M41742
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-12	1.82e-08	132	128	9	MM996
Coexpression	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV3-20	1.75e-05	32	128	4	M2118
Coexpression	GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	PPP4R1 ADAR SYNJ1 VCAN PACS2 CRYBG1 TMEM131	3.47e-05	184	128	7	M6739
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	6.23e-11	183	125	13	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	2.32e-10	163	125	12	Arv_SC-hpx_blastocyst_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	5.28e-10	175	125	12	Arv_SC-H9hpx_500_K3
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-9 IGKV1-6 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	8.83e-10	183	125	12	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	2.26e-08	244	125	12	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	IGKV1-39 IGKV1-33 IGKV1-17 OLFM4 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV3-20 IGKV3-11	5.86e-08	126	125	9	Arv_SC-HD_500_K2
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	IGKV1-39 IGKV1-33 IGKV1-17 OLFM4 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV3-20 IGKV3-11	1.37e-07	139	125	9	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2	IGKV1-39 IGKV1-33 IGKV1-9 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	4.03e-06	266	125	10	Arv_SC-hpx_blastocyst_1000_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11 HERC5	6.85e-06	492	125	13	Arv_SC-H9hpx_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 OLFM4 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11 HERC5	6.85e-06	492	125	13	Arv_SC-hpx_blastocyst_500
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 OLFM4 KIRREL2 NSUN7 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11 HERC5	6.70e-05	986	125	17	Arv_SC_fibroblast_1000
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 OLFM4 KIRREL2 NSUN7 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11 HERC5	6.70e-05	986	125	17	Arv_SC-HD_1000
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 OLFM4 KIRREL2 NSUN7 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11 HERC5	2.25e-04	987	125	16	Arv_SC-H9hpx_1000
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 OLFM4 KIRREL2 NSUN7 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11 HERC5	2.25e-04	987	125	16	Arv_SC-hpx_blastocyst_1000
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.38e-23	195	132	19	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.69e-23	197	132	19	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	8.82e-23	176	132	18	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-5 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	3.52e-21	175	132	17	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	5.21e-21	179	132	17	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	2.10e-20	194	132	17	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	2.51e-20	196	132	17	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	2.51e-20	196	132	17	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.59e-19	176	132	16	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.59e-19	176	132	16	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	5.08e-19	189	132	16	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	5.53e-19	190	132	16	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	5.53e-19	190	132	16	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	7.13e-19	193	132	16	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	9.14e-19	196	132	16	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11 PARP15	9.93e-19	197	132	16	2662138671262b30508c5759038bcdcfe6551696
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-5 RASSF6 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	4.27e-18	172	132	15	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	7.84e-18	179	132	15	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	7.84e-18	179	132	15	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-33 IGKV1-17 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.40e-17	186	132	15	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	IPF-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-5 RASSF6 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV3-20 IGKV3-11	1.40e-17	186	132	15	f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b
ToppCell	10x5'-GI_large-bowel\|World / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV3-20 IGKV3-11	1.10e-16	168	132	14	1290c909655bc37f6b8bf216d18127a21b99e9c0
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	2.31e-16	177	132	14	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	2.31e-16	177	132	14	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	2.31e-16	177	132	14	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV3-20 IGKV3-11	3.69e-16	183	132	14	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-17 IGKV1-9 IGKV1-6 EML6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	5.39e-16	188	132	14	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	6.74e-16	191	132	14	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	7.80e-16	193	132	14	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	6.89e-15	176	132	13	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	IPF-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-5 RASSF6 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV3-20 IGKV3-11	6.89e-15	176	132	13	cc0cab6487df6867b529596ec94f55d31aa6ca36
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-17 IGKV1D-13 IGKV3-20 IGKV3-11	9.93e-15	181	132	13	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.32e-14	185	132	13	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.32e-14	185	132	13	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-12 IGKV3-20 IGKV3-11	2.44e-14	194	132	13	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	2.61e-14	195	132	13	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 SEC24A IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV3-20 IGKV3-11	2.79e-14	196	132	13	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV3-20 IGKV3-11	6.03e-14	159	132	12	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	Control-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-5 RASSF6 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV3-20 IGKV3-11	1.35e-13	170	132	12	fb05f49b7113470995b3c16683c54dc1a660b73a
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 RASSF6 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-16 IGKV3-20 IGKV3-11	2.18e-13	177	132	12	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	COPD-Lymphoid-B_Plasma\|COPD / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-5 RASSF6 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV3-20	2.18e-13	177	132	12	1b872d3b1e0fca138362098590a634d748dfca60
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-16 IGKV1-12 ARHGAP24 IGKV1-5 RASSF6 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV3-20 IGKV3-11 PARP15	3.05e-13	182	132	12	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	3.25e-13	183	132	12	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	3.47e-13	184	132	12	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV3-20 IGKV3-11	3.70e-13	185	132	12	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV3-20 IGKV3-11	3.70e-13	185	132	12	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV3-11	7.81e-13	197	132	12	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV3-20 IGKV3-11	6.22e-12	178	132	11	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-33 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	7.03e-12	180	132	11	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	9.46e-12	185	132	11	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	9.46e-12	185	132	11	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-39 IGKV1-33 ARHGAP24 IGKV1-5 RASSF6 FER1L4 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	1.13e-11	188	132	11	c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV3-20 IGKV3-11	1.13e-11	188	132	11	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|COVID-19 / Condition, Lineage and Cell class	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-5 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV3-20 IGKV3-11 KNL1	1.50e-11	193	132	11	bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-17 IGKV1D-13 IGKV3-20 IGKV3-11	1.58e-11	194	132	11	f083777353e76a2d9c39f8b6cb1a689b68b81c56
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV3-20	1.67e-11	195	132	11	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV3-11	1.67e-11	195	132	11	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-16 IGKV1-12 ARHGAP24 IGKV1-5 IGKV3D-11 IGKV1D-39 IGKV1D-13 IGKV3-20 IGKV3-11 PARP15	1.87e-11	197	132	11	88b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 SEC24A IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-13 IGKV3-20 IGKV3-11	1.87e-11	197	132	11	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-13 IGKV1D-12	5.92e-11	162	132	10	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-13 IGKV1D-12	5.92e-11	162	132	10	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-9 IGKV1-6 ARHGAP24 LRP1B IGKV1-5 IGKV3D-20 IGKV1D-13 IGKV1D-12 IGKV3-20 PARP15	5.92e-11	162	132	10	b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-12 IGKV3-20 IGKV3-11	8.00e-11	167	132	10	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-12 IGKV3-20 IGKV3-11	8.00e-11	167	132	10	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV3-20 IGKV3-11	9.53e-11	170	132	10	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	Plasma_cells\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	1.13e-10	173	132	10	52a387e2a4694af61a9223a4c2ecf4e6f762c064
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV3-20 IGKV3-11	1.13e-10	173	132	10	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 FER1L4 IGKV1D-39 IGKV3-20 IGKV3-11	1.42e-10	177	132	10	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
ToppCell	VE-plasma\|VE / Condition, Cell_class and T cell subcluster	IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.42e-10	177	132	10	0c1cc0834de55717cb4f69d020339060ce2c9a03
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 FER1L4 IGKV1D-39 IGKV3-20 IGKV3-11	1.42e-10	177	132	10	111fb0707ff37ca631d85bb5a09e067ffe568eb8
ToppCell	VE-plasma-\|VE / Condition, Cell_class and T cell subcluster	IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV3-20 IGKV3-11	1.42e-10	177	132	10	3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	IGKV1-17 IGKV1-13 IGKV1-9 SEC24A IGKV1-5 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV3-20	1.97e-10	183	132	10	a6866951866373a1029e04818f4a4a31278c409d
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 FER1L4 IGKV3D-11 IGKV3-20 IGKV3-11	2.84e-10	190	132	10	a21d0c574abf21e7cb865a21a48f29c92d055fbe
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV3-20	3.66e-10	195	132	10	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	5'-Adult-LargeIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-13 IGKV3-20 IGKV3-11	3.66e-10	195	132	10	600174e35574fe7c44dd923adcf43686e7b01e39
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV3-20	3.85e-10	196	132	10	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Biopsy_Control_(H.)-Immune-Plasma_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-12 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV3-20 IGKV3-11	4.04e-10	197	132	10	275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-33 IGKV1-17 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV3-20 IGKV3-11 PARP15	4.04e-10	197	132	10	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-5 IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV3-20 IGKV3-11	4.39e-10	142	132	9	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 RASSF6 IGKV1D-33 IGKV1D-16 IGKV3-20	1.01e-09	156	132	9	4f92ca30755430db44402afc603d1ecd8bfc3617
ToppCell	390C-Lymphocytic-Plasma_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 RASSF6 IGKV1D-33 IGKV1D-16 IGKV3-20	1.01e-09	156	132	9	0de2fc695bd5f8d4633c514f71ea941c88137bac
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV3-20	1.20e-09	159	132	9	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-12 IGKV3-20	2.05e-09	169	132	9	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-12 IGKV3-20	2.16e-09	170	132	9	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-12 IGKV3-20	2.16e-09	170	132	9	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-12 IGKV3-20	2.16e-09	170	132	9	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	wk_08-11-Hematologic_Lymphocytic-B\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-13 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV3-11	2.40e-09	172	132	9	d1ab8f493b70ec995281f9fb0991f1d3aa7b928f
ToppCell	10x5'-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-13 IGKV1-6 IGKV1-5 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV3-20	2.52e-09	173	132	9	300904fd35536a69be81d76fe33fe16544523ceb
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-17 IGKV3-20 IGKV3-11	3.57e-09	180	132	9	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV3-20	4.13e-09	183	132	9	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV3-20	4.13e-09	183	132	9	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-16 IGKV3-20 IGKV3-11	4.33e-09	184	132	9	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-16 IGKV3-20 IGKV3-11	4.33e-09	184	132	9	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-9 IGKV3D-20 IGKV1D-39 IGKV1D-13 IGKV3-20 IGKV3-11	4.76e-09	186	132	9	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV3D-11 IGKV1D-39 IGKV3-20	4.76e-09	186	132	9	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 ARHGAP24 IGKV1-5 IGKV1D-33 IGKV3-20 PARP15	7.85e-09	197	132	9	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	COVID_vent-Lymphocytic-Plasma_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-9 SEC24A IGKV3D-20 IGKV3D-11 IGKV1D-39 IGKV1D-33 IGKV3-20 IGKV3-11	8.21e-09	198	132	9	e84c5f712e1dea548d0e2aba6625598f9671d3a0
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 ARHGAP24 IGKV1-5 IGKV1D-39 IGKV3-20 PARP15	8.21e-09	198	132	9	d51ee880acc5804cd918105fac846a1528333d6c
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	IGKV1-39 IGKV1-17 IGKV1-9 EML6 IGKV1-5 IGKV3D-20 IGKV1D-39 IGKV3-20 IGKV3-11	8.58e-09	199	132	9	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	10x5'-Lung-Lymphocytic_B-Naive_B_cells\|Lung / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-12 ARHGAP24 IGKV1-5 IGKV1D-39 IGKV1D-13 IGKV3-20 IGKV3-11	3.45e-08	165	132	8	1776e7db80d7cf6b449fa8635a111705a59231b4
Disease	COMM domain-containing protein 1 measurement	IGKV1-17 IGKV1-16	1.59e-05	2	118	2	EFO_0802424
Disease	level of nuclear factor NF-kappa-B p105 subunit in blood serum	IGKV1-17 IGKV1-16	1.59e-05	2	118	2	OBA_2040323
Disease	congenital muscular dystrophy (implicated_via_orthology)	COL6A3 DYNC1H1	2.35e-04	6	118	2	DOID:0050557 (implicated_via_orthology)
Disease	alcohol dependence, risky sexual behaviour measurement	FSTL5 HMG20A	4.37e-04	8	118	2	EFO_0007877, MONDO_0007079
Disease	lung cancer (implicated_via_orthology)	TPR ROBO1	5.60e-04	9	118	2	DOID:1324 (implicated_via_orthology)
Disease	liver fat measurement	OLFM4 RIOX2 RASSF6	6.85e-04	43	118	3	EFO_0010821
Disease	Marfan syndrome (implicated_via_orthology)	MATN3 BMP2	6.99e-04	10	118	2	DOID:14323 (implicated_via_orthology)
Disease	interleukin-6 measurement, response to stimulus	FSTL5 MUC16	8.52e-04	11	118	2	EFO_0004810, GO_0050896
Disease	Hypermetropia, Myopia	CEL CUBN PNPT1 CNTNAP5 TBX20	9.97e-04	189	118	5	HP_0000540, HP_0000545
Disease	disease recurrence, colon carcinoma	BMP2 ANAPC2 MACF1	1.13e-03	51	118	3	EFO_0004952, EFO_1001950
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 PNPT1	1.20e-03	13	118	2	C1846647
Disease	Peripheral Nervous System Diseases	PPARD PNPLA6 GAN	1.33e-03	54	118	3	C4721453
Disease	insulin metabolic clearance rate measurement, glucose homeostasis measurement	ZZEF1 HMG20A	1.40e-03	14	118	2	EFO_0006830, EFO_0006896
Disease	idiopathic pulmonary fibrosis	DNAJB4 AKAP13 KNL1	1.56e-03	57	118	3	EFO_0000768
Disease	Proteinuria	CUBN FAM151B	1.61e-03	15	118	2	HP_0000093
Disease	hepcidin:transferrin saturation ratio	EML6 MUC16	1.61e-03	15	118	2	EFO_0007902
Disease	primary autosomal recessive microcephaly (is_implicated_in)	TRAPPC14 KNL1	1.83e-03	16	118	2	DOID:0070296 (is_implicated_in)
Disease	response to radiation, Urinary retention	COL6A3 LRP1B	2.07e-03	17	118	2	GO_0009314, HP_0000016
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	PDXDC1 ACACB ITIH3 DNAH1 MACF1	2.11e-03	224	118	5	EFO_0004530, EFO_0008317
Disease	food allergy measurement, parental genotype effect measurement	DCHS2 EML6	2.33e-03	18	118	2	EFO_0005939, EFO_0007016
Disease	cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant	PDE1A CDH23	2.59e-03	19	118	2	EFO_0007044, EFO_0020106
Disease	response to methotrexate, neurotoxicity	PNPLA6 MACF1	2.59e-03	19	118	2	EFO_0011057, GO_0031427
Disease	melanoma	PCDHB8 PPARD CUBN LRP1B CRYBG1	3.26e-03	248	118	5	C0025202
Disease	Autosomal Recessive Primary Microcephaly	TRAPPC14 KNL1	3.48e-03	22	118	2	C3711387
Disease	urate measurement, bone density	ARHGAP24 FSTL5 ETS2 COL6A5 HMG20A DNAH1 CNTNAP5 ROBO1	3.49e-03	619	118	8	EFO_0003923, EFO_0004531
Disease	axial length measurement	HMG20A BMP2 ZNRF3	3.68e-03	77	118	3	EFO_0005318
Disease	mean arterial pressure	PDE1A ARHGAP24 FBXL13 EML6 PPARD ZNRF3 ROBO1	4.00e-03	499	118	7	EFO_0006340

Protein segments in the cluster

Peptide	Gene	Start	Entry
LPASIEFRESSEDSF	AFDN	601	P55196
IEELFSIVRDFPDSR	ANAPC2	341	Q9UJX6
VELTRFETLTPRFSA	BIRC6	1026	Q9NR09
LDTSRIITESFFEVP	VCAN	1671	P13611
SVPEVFELSLSIFLT	ARFGEF1	496	Q9Y6D6
SAVLLVDETATTPIF	AKAP13	1876	Q12802
SSVPDVFELSLAIFL	ARFGEF2	446	Q9Y6D5
SVPVDSFFSLLTSER	ACAD10	116	Q6JQN1
TFDPSVVEIFLALSS	AASDH	241	Q4L235
EPADTAFLLERVSIS	ABCD4	381	O14678
LFSSSAVPFLEEQVT	ANO9	361	A1A5B4
DFETDVLFLVPTEIA	CEL	406	P19835
LSSIPTEEFITSAEL	BMP2	136	P12643
QPLDRETKSEFTVEF	CDH23	91	Q9H251
FDASRTDPTVLVFVE	NDST3	71	O95803
ETSIFIPAFESETKV	RASSF6	221	Q6ZTQ3
TSFAVFDDTLLIVDP	EXOSC8	196	Q96B26
LRPVTAFTLEATVDT	KIAA1549	921	Q9HCM3
FTLTISSLEPEDFAV	IGKV3D-11	91	A0A0A0MRZ8
LILSETTIFDVLPTF	ACACB	1266	O00763
LNVTSILDREETPFF	DSG2	111	Q14126
STTTLEVSQPFFIEI	OVOS1	671	Q6IE37
DTFTGEIPRVFTSSI	MUC16	5246	Q8WXI7
APETVVALFSVSDLD	PCDHB13	361	Q9Y5F0
STVLRLPVEAFSAVF	PNPLA6	291	Q8IY17
LTTVEVLSFSSITFP	PARP15	191	Q460N3
LLDVFTPATSIEDFS	MAPK11	86	Q15759
TDFTFTISSLQPEDI	IGKV1D-33	91	P01593
TDFTLTISSLQPEDF	IGKV1D-39	91	P04432
FPFLTSSERLEVVSR	HOGA1	81	Q86XE5
FITAFTVPDIDDVTV	LRP1B	1596	Q9NZR2
FIIDSSRSVRPLEFT	MATN3	86	O15232
VTFQVDTASDSPFLI	KCNJ10	236	P78508
TDFTLTISSLQPEDF	IGKV1D-12	91	P01611
DFTLTISRLEPEDFA	IGKV3D-20	91	A0A0C4DH25
ETTDEIPFSFSDRLR	MALT1	806	Q9UDY8
SLTAIPLEIFTFTEL	LRRIQ4	36	A6NIV6
KERSVFDIPIFTEEF	HMG20A	211	Q9NP66
ISLPAETELTVAVFD	FER1L4	1306	A9Z1Z3
TDFTLTISSLQPEDF	IGKV1D-13	91	A0A0B4J2D9
FAVSAESLPETLVIF	DYNC1LI2	121	O43237
DDTLISTPDLVFAFS	EXTL2	151	Q9UBQ6
IDFIVEPTFSLLTDS	PDE1A	421	P54750
DFIVEPTFSVLTDVA	PDE1B	426	Q01064
VEDELSSPVVVFRFF	PDXDC1	381	Q6P996
SLLDVQRVPSFESFE	ETS2	301	P15036
LDTVISFFPDVTFSL	FAM151B	151	Q6UXP7
VTLFPEEVIATIFSS	INSIG1	111	O15503
FVTPDTDIKVTLSIF	NCKAP1L	946	P55160
FPEFAERIEASLSEV	MACF1	141	O94854
TEFTLTISSLQPEDF	IGKV1D-17	91	A0A075B6S4
LTITFEESVVGFPFL	KNL1	2156	Q8NG31
TTTLEVSQPFFIEIA	OVOS2	771	Q6IE36
PEAEASTLDVFTERL	PACS2	391	Q86VP3
PALEVTEEFFSTLDS	PLEKHM3	11	Q6ZWE6
DRVDDFFIPTTTLII	FSTL5	596	Q8N475
AFLPSEAVEITEDSL	DCHS2	2346	Q6V1P9
RESEFALRPTFDLTV	HERC5	671	Q9UII4
TLFFPSAIERVSEAI	ABCC4	366	O15439
FSTFGELTVEPRRTE	ARHGAP24	726	Q8N264
IELKFSDFDVVPSTS	CUBN	3076	O60494
EDFTFVSLLTRPEVI	DNAH1	496	Q9P2D7
TTEALERTFLAFPAT	HBQ1	26	P09105
LIEFEVSFPDTISSS	DNAJB4	311	Q9UDY4
LTTFEAAPATEESLI	DRAXIN	191	Q8NBI3
DEIPRDFTTLFDLSI	IFT52	281	Q9Y366
SVSEDLLEPFIAVSA	ADAR	236	P55265
EFSRLTSLVPFVDAF	EIF3A	451	Q14152
FRDVSSTEEFLELSP	GAN	161	Q9H2C0
ALDISPTVFAFDERV	COL6A5	1891	A8TX70
ELEEIAFDSSLVFIP	COL6A3	591	P12111
FPERSSSEVFLVDET	FBXL13	136	Q8NEE6
IIRFSSPFDIADTST	IFNGR2	156	P38484
EDIFISVLFAPTRLS	CEP192	1836	Q8TEP8
TVDFEIATKEDPRSF	DYNC1H1	4621	Q14204
LEVVADASFLTEPVS	KIRREL2	276	Q6UWL6
TEFTLTISSLQPDDF	IGKV1-5	91	P01602
TDFTLTISSLQPEDF	IGKV1-6	91	A0A0C4DH72
TEFTLTISSLQPEDF	IGKV1-9	91	A0A0C4DH69
TDFTLTISSLQPEDF	IGKV1-12	91	A0A0C4DH73
TDFTLTISSLQPEDF	IGKV1-13	91	P0DP09
TDFTLTISSLQPEDF	IGKV1-16	91	P04430
TEFTLTISSLQPEDF	IGKV1-17	91	P01599
TDFTFTISSLQPEDI	IGKV1-33	91	P01594
TDFTLTISSLQPEDF	IGKV1-39	91	P01597
FTLTISSLEPEDFAV	IGKV3-11	91	P04433
DFTLTISRLEPEDFA	IGKV3-20	91	P01619
LERIFVVEFRPDSDT	EML6	1506	Q6ZMW3
SLRFIDVEFSEPTII	CRYBG1	1491	Q9Y4K1
IVADTFRDFAVSTVP	DDAH2	151	O95865
TFTINESTIIDSPRF	HEXB	186	P07686
LSSLFAAEVFPTVIR	SLC22A31	441	A6NKX4
TFIFVRLPEEDASSQ	HELB	696	Q8NG08
DFIRLEISSPSEITF	CNTNAP5	836	Q8WYK1
APETVVALFSVSDLD	PCDHB8	361	Q9UN66
TEDVAPADIVSFLLT	OTOG	1281	Q6ZRI0
FPEFFLTITSILETQ	UTP20	126	O75691
PAFDFVILLDVSDTS	SPEF2	776	Q9C093
ESDVIIIPSALDFVS	PPP4R1	26	Q8TF05
TVRELTEFAKSIPSF	PPARD	256	Q03181
FRVTSTEFISLRIDS	SYNJ1	96	O43426
ELDTPESARIIAFIS	SEC24A	1026	O95486
EVSFDVELPKTAFIT	ITIH3	76	Q06033
FLSILTRERDPSETV	NSUN7	501	Q8NE18
SLEVEPFASLTEAVR	SIRT3	321	Q9NTG7
LERALDATEVPFSIT	TEKT4	126	Q8WW24
VFVTFPLEEDETVSL	IARS1	206	P41252
PRLVFISQVTTESEF	SEC31B	416	Q9NQW1
FPFTIRVTSEVLESN	PNPT1	466	Q8TCS8
DTTFPVDRVERLEFT	OLFM4	91	Q6UX06
SEESVVLSFPRFTLE	SERPINB12	291	Q96P63
EFVDLSVPRTFSTQI	AHNAK2	5486	Q8IVF2
FTLFLETVEPVAVES	C10orf126	71	Q8N4M7
PLTFRDVAIEFSLEE	ZNF273	36	Q14593
SVTLELAEAPRFESI	SPEG	1476	Q15772
STDEVIFPLTVSLDR	TRAPPC14	146	Q8WVR3
FFDDEDRTVPSTPTL	TPR	2126	P12270
DTRVLFDPFELDTSV	PWP2	731	Q15269
PASERFAATTVEEIL	TNKS1BP1	151	Q9C0C2
SRDIIILFTPDFTAS	TMEM131	1061	Q92545
SEVAELTVLERPSFV	ROBO1	251	Q9Y6N7
LTEVSISSDAFFPFR	ATIC	531	P31939
LFESLISPIKTETFF	RIOX2	41	Q8IUF8
FETIVSALDELDIPF	ZNF862	671	O60290
TFLSPNVLEEVDSFL	ZZEF1	446	O43149
KETAFVEVVLFESSP	ZNRF3	56	Q9ULT6
LKSEEFRTFIFPETV	TBX20	246	Q9UMR3
TIDKFTRFTDVPLAA	TARBP1	1376	Q13395
PTSSSQRSFVEFILE	EFTUD2	361	Q15029
FTTFELFLTVIDAPA	TRPV5	531	Q9NQA5
GPLTFRDVTIEFSLE	ZNF729	11	A6NN14
TDFTLTISSLQPEDF	IGKV1D-16	91	P01601
FTSISEIFSDLDPDV	N4BP2	51	Q86UW6